Table 2.
Variations in Definitions of ACLF Worldwide
| Consortium | ||||
|---|---|---|---|---|
| APASL | EASL‐CLIF | NACSELD | WGO | |
| Diagnostic parameters | Acute jaundice and coagulopathy, followed by ascites ± HE <4 weeks in undiagnosed or diagnosed chronic liver disease, including cirrhosis | Specified criteria using CLIF‐OF score(s) for OF, 28‐day mortality rate >15% from AD of cirrhosis, without/with prior decompensation often caused by infection | Specified criteria for ≥2 OFs in patients with infection, at or during admission | Acute hepatic decompensation resulting in jaundice, elevated INR, and ≥1 or more OFs, with increased mortality in 28‐90 days, with or without previously diagnosed cirrhosis |
| Exclusion criteria | Bacterial infection or previous AD | Patients admitted electively for procedures or therapy, or those with hepatocellular carcinoma outside Milan criteria, or receiving immunosuppressive therapy, with HIV or with severe chronic extrahepatic disease | Outpatients with infection, any patient with HIV infection, prior organ transplants, or disseminated malignancies | None stated |